AudioMedica
Home of the Audio Journal of OncologyInterviews with the world's key opinion leaders in cancer
EpisodesArchivesAboutHave Your Say

AudioMedica

Connecting healthcare professionals with the latest oncology updates through audio.

Explore

  • Episodes
  • Archives
  • Topics
  • Speakers

Company

  • About Us
  • Have Your Say
  • Contact
  • Privacy Policy

Subscribe

Get the latest updates directly to your inbox.

© 2026 AudioMedica. All rights reserved.

Search

Filters

Topics

Series

Speakers

995 results found in 1ms
  1. Live Report from ASH:<br />Interleukin-2 For Acute Myeloid Leukemia In First Remission?
    Audio Journal of Oncology

    Live Report from ASH:<br />Interleukin-2 For Acute Myeloid Leukemia In First Remission?

    Jonathan Kolitz JONATHAN KOLITZ, Monter Cancer Center, Lake Success, NY GEORGE CANELLOS, Dana-Farber Cancer Institute For patients with acute myeloid leukemia in first remission, new data suggests tha

    10/12/2007
    Details
  2. New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura
    Audio Journal of Oncology

    New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura

    Terry Gernsheimer TERRY GERNSHEIMER, University of Washington Medical Center, Seattle An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chroni

    09/12/2007
    Details
  3. No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia
    Audio Journal of Oncology

    No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia

    Zakari Aliyu REFERENCE: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta ZAKARI ALIYU, Howard University, Washington DC Nigeria has the highest incidence of sickle cell anemi

    09/12/2007
    Details
  4. Large Risk Reduction For Rivaroxaban In Blood Clot Prevention
    Audio Journal of Oncology

    Large Risk Reduction For Rivaroxaban In Blood Clot Prevention

    Bengt Eriksson REFERENCE: Abstract 6, American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta BENGT ERIKSSON, Gothenburg University In a large phase III trial of patients having a h

    09/12/2007
    Details
  5. Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
    Audio Journal of Oncology

    Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

    Jean-Yves Douillard Gordon McVie REFERENCE: Abstracts: 6507 & 2LB, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 JEAN-YVES DOUILLARD, Centre René Gauducheau, N

    16/11/2007
    Details
  6. Protective Cardiovascular Benefit for Women on HRT For Natural Menopause
    Audio Journal of Oncology

    Protective Cardiovascular Benefit for Women on HRT For Natural Menopause

    George Sopko

    06/11/2007
    Details
  7. Oral Contraceptive Use: More Carotid and Femoral Atheroschlerosis Later in Life
    Audio Journal of Oncology

    Oral Contraceptive Use: More Carotid and Femoral Atheroschlerosis Later in Life

    Ernst Rietzschel Jennifer Mieres REFERENCE: News Briefing, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida N Engl J Med 2007;357 ERNST RIETZSCHEL, University of Gh

    06/11/2007
    Details
  8. TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?
    Audio Journal of Oncology

    TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?

    Gregg Stone REFERENCE: Abstract 2357, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida GREGG STONE, Columbia University, New York New light has been thrown on the u

    06/11/2007
    Details
  9. Torcetrapib in Patients at High Risk for Coronary Events: ILLUMINATE Trial Latest Results
    Audio Journal of Oncology

    Torcetrapib in Patients at High Risk for Coronary Events: ILLUMINATE Trial Latest Results

    Philip Barter Gordon Tomaselli REFERENCE: Late Breaking Clinical Trials, Session 2, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida N Engl J Med 2007;357 PHILIP BA

    06/11/2007
    Details
  10. Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results
    Audio Journal of Oncology

    Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results

    Ake Hjalmarson Gordon Tomaselli REFERENCE: Late Breaking Clinical Trials, Session 2, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida N Engl J Med 2007;357 AKE HJAL

    06/11/2007
    Details
  11. Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study
    Audio Journal of Oncology

    Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study

    Uwe Zeymer REFERENCE: Late Breaking Clinical Trials Session I, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida UWE ZEYMER, Herzzentrum Ludwigshafen, Germany The gl

    06/11/2007
    Details
  12. TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?
    Audio Journal of Oncology

    TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?

    Gordon Tomaselli Daniel Jones REFERENCE: Late Breaking Clinical Trials 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida GORDON TOMASELLI, Johns Hopkins Universit

    05/11/2007
    Details
  • ‹‹
  • ‹
  • 55
  • 56
  • 57
  • 58
  • 59
  • ›
  • ››